New York Codes, Rules and Regulations › Title 10 - DEPARTMENT OF HEALTH › Chapter I - State Sanitary Code › Part 9 - Prohibited Substances › Subpart 9-1 - Synthetic Phenethylamines And Synthetic Cannabinoids Prohibited › Section 9-1.1 - Definitions

Current through Register Vol. 46, No. 28, July 10, 2024
(a) Synthetic
				  phenethylamine means any of the following chemical compounds, that are not
				  listed as a controlled substance in schedules I through V of section 3306  of the Public Health Law, and are not
				  approved by the Federal Food and Drug Administration (FDA):
3,4-Methylenedioxymethcathinone (Methylone);
4-Methoxymethcathinone;
3-Fluoromethcathinone;
4-Fluoromethcathinone;
Ethylpropion (Ethcathinone);
2-(2,5-Dimethoxy-4-ethylphenyl)ethanamine (2C-E);
2-(2,5-Dimethoxy-4-methylphenyl)ethanamine (2C-D);
2-(4-Chloro-2,5-dimethoxyphenyl)ethanamine (2C-C);
2-(4-Iodo-2,5-dimethoxyphenyl)ethanamine (2C-I);
2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine
					 (2C-T-2);
2-[4-(Isopropylthio)-2,5-dimethoxyphenyl]ethanamine
					 (2C-T-4);
2-(2,5-Dimethoxyphenyl)ethanamine (2C-H);
2-(2,5-Dimethoxy-4-nitro-phenyl)ethanamine (2C-N);
2-(2,5-Dimethoxy-4-(n)-propylphenyl)ethanamine (2C-P);
					 and
any compound that has a chemical structure that is
					 substantially similar to these compounds.
(b) Synthetic Cannabinoid means any
				  manufactured chemical compound that is a cannabinoid receptor agonist and
				  includes, but is not limited to any material, compound, mixture, or preparation
				  that is not listed as a controlled substance in Schedules I through V of §
										3306 of the Public Health Law, and not
				  approved by the federal Food and Drug Administration (FDA), and contains any
				  quantity of the following substances, their salts, isomers (whether optical,
				  positional, or geometric), homologues (analogs), and salts of isomers and
				  homologues (analogs), unless specifically exempted, whenever the existence of
				  these salts, isomers, homologues (analogs), and salts of isomers and homologues
				  (analogs) is possible within the specific chemical designation:
(1) Naphthoylindoles. Any compound containing
				  a 3-(1- Naphthoyl)indole structure with substitution at the nitrogen atom of
				  the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkyl-
				  ethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group,
				  whether or not further substituted in the indole ring to any extent and whether
				  or not substituted in the naphthyl ring to any extent. (Other names in this
				  structural class include but are not limited to: JWH 007, JWH 015, JWH 018, JWH
				  019, JWH 073, JWH 081, JWH 98, JWH 122, JWH 164, JWH 200, JWH 210, JWH 398, AM
				  2201, MAM 2201, EAM 2201 and WIN 55 212.)
(2) Naphthylmethylindoles. Any compound
				  containing a 1 H-indol- 3-yl-(1- naphthyl)methane structure with substitution
				  at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,
				  cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-
				  morpholinyl)ethyl group, whether or not further substituted in the indole ring
				  to any extent and whether or not substituted in the naphthyl ring to any
				  extent. (Other names in this structural class include but are not limited to:
				  JWH-175, and JWH-184.)
(3)
				  Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl) pyrrole structure
				  with substitution at the nitrogen atom of the pyrrole ring by an alkyl,
				  haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-
				  methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not
				  further substituted in the pyrrole ring to any extent and whether or not
				  substituted in the naphthyl ring to any extent. (Other names in this structural
				  class include but are not limited: JWH 307.)
(4) Naphthylmethylindenes. Any compound
				  containing a naphthylm-ethyl indenes structure with substitution at the
				  3-position of the indene ring by an alkyl, haloalkyl, alkenyl,
				  cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or
				  2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene
				  ring to any extent and whether or not substituted in the naphthyl ring to any
				  extent. (Other names in this structural class include but are not limited:
				  JWH-176.)
(5) Phenylacetylindoles.
				  Any compound containing a 3-phenylacetylindole structure with substitution at
				  the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,
				  cycloalkylmethyl, cycloal-kylethyl, 1-(N-methyl-2-piperidinyl)methyl, or
				  2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole
				  ring to any extent and whether or not substituted in the phenyl ring to any
				  extent. (Other names in this structural class include but are not limited to:
				  RCS-8 (SR- 18), JWH 201, JWH 250, JWH 203, JWH-251, and JWH-302.)
(6) Cyclohexylphenols. Any compound
				  containing a 2-(3- hydroxycyclohexyl)phenol structure with substitution at the
				  5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl,
				  cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-
				  morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to
				  any extent. (Other names in this structural class include but are not limited
				  to: CP 47,497 (and homologues (analogs)), cannabicyclohexanol, and CP
				  55,940.)
(7) Benzoylindoles. Any
				  compound containing a 3-(benzoyl)indole structure with substitution at the
				  nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,
				  cycloalkylmethyl, cycloalkylethyl, 1-(N-methy1- 2-piperidinyl)methyl, or
				  2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole
				  ring to any extent and whether or not substituted in the phenyl ring to any
				  extent. (Other names in this structural class include but are not limited to:
				  AM 694, Pravadoline (WIN 48,098), RCS 4, AM-2233 and AM-679.)
(8)
				  [2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3- de]-1,
				  4-benzoxazin-6-yl]-1-napthalenylmethanone. (Other names in this structural
				  class include but are not limited to: WIN 55,212-2.)
(9) (6aR,10aR)-9-(hydroxymethyl)-6,
				  6-dimethyl-3-(2-methyloctan- 2-yl)-6a,7,10, 10a- tetrahydrobenzochromen-1-ol.
				  (Other names in this structural class include but are not limited to:
				  HU-210.)
(10) (6aS,
				  10aS)-9-(hydrxymethyl)-6,6-demethyl-3-(2-methyloctan-
				  2-yl)-6a,7,10,10a-tetrahydrobenzo{c}chromen-l-ol (Dezanabinol or HU-
				  211)
(11) Adamantoylindoles. Any
				  compound containing a 3-(1- adamantoyl)indole structure with substitution at
				  the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl,
				  cycloalkylmethyl, cycloalkyl- ethyl, 1-(N-methyl-2-piperidinyl)methyl, or
				  2-(4-morpholinyl)ethyl group, whether or not further substituted in the
				  adamantyl ring system to any extent. (Other names in this structural class
				  include but are not limited to: AM-1248.)
(12) Adamantoylindazoles including but not
				  limited to Adamantyl Carboxamide Indazoles. Any compound containing a 3-(1-
				  adamantoyl)indazole structure with substitution at the nitrogen atom of the
				  indazole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl,
				  cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4- morpholinyl)ethyl
				  group, whether or not further substituted in the adamantyl ring system to any
				  extent. (Other names in this structural class include but are not limited to:
				  AKB-48, MAB-CHMINACA, 5F-AKB-48.)
(13) Tetramethylcyclopropylcarbonylindoles or
				  any compound structurally derived from
				  3-(2,2,3,3-tetramethylcyclopropylcarbonyl) indole by substitution at the
				  nitrogen atom of the indole ring with alkyl,haloalkyl, alkenyl, cyanoalkyl,
				  hydroxyalkyl, cycloalkylmethyl, cycloalkylethyl, (N-methylpiperidin-2-yl)methyl
				  or 2-(4- morpholinyl)ethyl, whether or not further substituted in the indole
				  ring to any extent, including without limitation the following: UR-11, XLR-11,
				  A-796,260.
(14) Any other synthetic
				  chemical compound that is a cannabinoid receptor agonist that is not listed in
				  Schedules I through V of §
											3306 of the Public Health Law, or is not an
				  FDA approved drug.